Safety and Tolerability Study of Recombinant L-IFN Adenovirus Injection in Patients With Recurrent Glioblastoma

NCT05914935 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

UNKNOWN

Status

6

Enrollment

OTHER

Sponsor class

Conditions

Recurring Glioblastoma

Interventions

DRUG: Recombinant L-IFN adenovirus injection

Sponsor

Binhai Hospital of Fujian Medical University

Collaborators

[object Object]